Phase 4: Investigational Study to Evaluate Metformin XR Monotherapy Versus Metformin IR Monotherapy in Subjects With Type 2 Diabetes

NCT01864174 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

1736

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Metformin XR
DRUG: Metformin IR
DRUG: Placebo matching with Metformin XR
DRUG: Placebo matching with Metformin IR

Sponsor

Bristol-Myers Squibb